Metabolic and transport machinery – physiological substrate role

The term "Metabolic and transport machinery – physiological substrate role" is a functional classification used in pharmacological databases, such as the IUPHAR/BPS Guide to Pharmacology, to identify proteins that interact with drugs as part of the body's natural processing systems (Alexander et al., 2023). This category does not represent a single therapeutic target but rather a collective system of enzymes and transporters, including the Cytochrome P450 (CYP) superfamily and various ATP-binding cassette (ABC) and solute carrier (SLC) transporters (UniProt Consortium, 2023). These components are responsible for the absorption, distribution, metabolism, and excretion (ADME) of xenobiotics and endogenous substances (NIH/NCBI, 2024). While these proteins are not typically the intended site of action for a drug's therapeutic effect, their role as a "physiological substrate" is a primary determinant of a drug's pharmacokinetic profile and systemic exposure. For biotech analysts, this classification is critical for assessing the risk of drug-drug interactions (DDIs), where a candidate molecule may compete for or alter the activity of these metabolic pathways (StatPearls, 2024). Furthermore, genetic polymorphisms within this machinery can lead to significant inter-individual variability in drug response and toxicity, necessitating careful consideration during clinical trial design and patient stratification (PubMed, 2024).

Other names

ADME machineryDrug metabolism and transport systemPhysiological substrate processingPharmacokinetic machinery

The molecule acts as a substrate for endogenous metabolic enzymes (facilitating chemical biotransformation) and membrane transport proteins (facilitating movement across biological barriers).